UNICA IRIS Institutional Research Information System

FADDA, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 210.863
NA - Nord America 16.825
AS - Asia 6.428
SA - Sud America 1.041
Continente sconosciuto - Info sul continente non disponibili 594
AF - Africa 196
OC - Oceania 20
Totale 235.967
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 202.009
US - Stati Uniti d'America 16.431
NL - Olanda 5.126
SG - Singapore 2.491
CN - Cina 2.160
SE - Svezia 836
UA - Ucraina 827
BR - Brasile 818
DE - Germania 513
VN - Vietnam 502
FI - Finlandia 443
GB - Regno Unito 423
FR - Francia 297
IN - India 213
CA - Canada 207
HK - Hong Kong 197
KR - Corea 149
BD - Bangladesh 122
TR - Turchia 89
AR - Argentina 74
IQ - Iraq 71
RU - Federazione Russa 71
MX - Messico 70
JP - Giappone 57
ES - Italia 55
PL - Polonia 54
EC - Ecuador 41
SA - Arabia Saudita 41
ZA - Sudafrica 40
PK - Pakistan 36
MA - Marocco 34
UZ - Uzbekistan 33
VE - Venezuela 30
AT - Austria 29
BE - Belgio 29
PH - Filippine 29
ID - Indonesia 27
CO - Colombia 26
IL - Israele 26
NP - Nepal 23
CZ - Repubblica Ceca 22
GR - Grecia 22
IE - Irlanda 22
JO - Giordania 21
KE - Kenya 21
AE - Emirati Arabi Uniti 18
IR - Iran 18
MY - Malesia 18
AU - Australia 17
JM - Giamaica 17
EG - Egitto 16
CL - Cile 15
CR - Costa Rica 14
ET - Etiopia 14
TT - Trinidad e Tobago 13
BO - Bolivia 12
CH - Svizzera 12
EU - Europa 12
LT - Lituania 12
SC - Seychelles 12
LB - Libano 11
PY - Paraguay 11
AZ - Azerbaigian 10
DZ - Algeria 10
NI - Nicaragua 10
PA - Panama 10
TN - Tunisia 10
RS - Serbia 9
DO - Repubblica Dominicana 8
HN - Honduras 8
KZ - Kazakistan 8
SV - El Salvador 8
HU - Ungheria 7
OM - Oman 7
PR - Porto Rico 7
PT - Portogallo 7
TH - Thailandia 7
GE - Georgia 6
HR - Croazia 6
NG - Nigeria 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
BS - Bahamas 5
CI - Costa d'Avorio 5
PE - Perù 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
GT - Guatemala 4
KG - Kirghizistan 4
RO - Romania 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
KH - Cambogia 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
Totale 235.323
Salva come PNG Salva come JPEG
Città #
Cagliari 196.337
Amsterdam 5.056
Uta 4.633
Ashburn 2.025
Singapore 1.224
Fairfield 1.057
San Jose 972
Chandler 870
Woodbridge 841
Dallas 747
Ann Arbor 683
Houston 619
Boardman 555
Jacksonville 450
Seattle 449
Nyköping 443
Wilmington 410
Beijing 357
Cambridge 357
Council Bluffs 339
Los Angeles 331
Dearborn 290
Helsinki 269
New York 260
Santa Clara 213
Hefei 193
Hong Kong 179
Shanghai 176
Nanjing 167
Lauterbourg 161
The Dalles 155
Boston 153
Seoul 139
Ho Chi Minh City 130
Hanoi 116
Milan 105
Buffalo 88
Rome 83
Columbus 81
Munich 80
Orem 79
São Paulo 79
Atlanta 74
San Diego 72
Toronto 68
Denver 67
Shenyang 64
London 63
Guangzhou 62
Dong Ket 61
Chicago 60
Chennai 57
Brooklyn 55
Frankfurt am Main 54
Redwood City 53
San Francisco 53
Phoenix 50
Washington 50
Tianjin 48
Montreal 47
Tokyo 46
Nanchang 43
Princeton 42
Redondo Beach 42
Mountain View 41
Warsaw 40
Sassari 39
Verona 36
Jiaxing 34
Turku 33
Manchester 32
Hebei 31
Kocaeli 30
Tashkent 30
Norwalk 29
Changsha 28
Madrid 28
Pune 28
Baghdad 27
Paris 27
Brussels 26
Nuremberg 26
Wuhan 25
Stockholm 24
North Bergen 23
Las Vegas 22
Orange 22
Johannesburg 21
Mumbai 21
Poplar 21
Rio de Janeiro 21
Belo Horizonte 20
Brasília 20
Da Nang 20
Kunming 20
Newark 20
Dhaka 19
Dublin 19
Mexico City 19
Nairobi 19
Totale 224.123
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.693
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.169
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function 4.500
Maternal immune activation disrupts dopamine system in the offspring 4.177
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.926
BEHAVIORAL EFFECTS OF ACUTE ADMINISTRATION OF THE PPAR-α AGONIST PALMITOYLETHANOLAMIDE IN RATS 3.431
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.424
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.410
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.359
Emotional profile of female rats showing binge eating behavior 3.280
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.251
Sex differences in addictive disorders 3.196
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats 3.193
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.119
Acute administration of palmitoylethanolamide: behavioural studies 3.022
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.993
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.976
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.924
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.895
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings 2.887
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.863
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.843
Antidepressant-like effect of clofibrate: a synthetic PPAR-a agonist 2.813
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.739
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.622
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.614
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission 2.607
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.533
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.490
Piano di uguaglianza di genere dell’Università degli Studi di Cagliari 2.480
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.422
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.414
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 2.400
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.399
Brain activity of anandamide: a rewarding bliss? 2.295
Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview 2.287
Increased cannabinoid intravenous self-administration in the olfactory bulbectomy rats model of depression 2.262
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.258
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.248
Methoxetamine affects brain processing involved in emotional response in rats 2.199
Animal Models of Eating Disorders 2.181
Analysis of opioid-seeking reinstatement in the rat 2.150
The GABA(B) receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats 2.117
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.039
Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo (3.2.1) octanes 2.001
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.971
null 1.948
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.919
Chronic Blockade of CB1 Receptors Reverses Startle Gating Deficits and Associated Neurochemical Alterations in Isolation Reared Rats. 1.913
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.885
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.781
Sex differences in the self-administration of cannabinoids and other drugs of abuse 1.761
THC exposure during adolescence increases cannabinoid and heroin intake in female rats more than in males 1.737
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.706
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats 1.679
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.669
null 1.579
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.533
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.517
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.475
Effects of modulation of endocannabinoid system on fat intake under a limited-access protocol of binge eating in female rats 1.474
The endocannabinoid system and nondrug rewarding behaviours 1.474
Hippocampal theta activity is modulated by cannabinoid type1receptor in rats 1.452
Drug and cue induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones 1.418
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.387
Differential effects of THC-or CBD-rich cannabis extracts on working memory in rats 1.327
Neurobiological mechanisms of cannabinoid addiction 1.314
Cannabinoids and their therapeutic applications in mental disorders 1.304
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.295
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats 1.195
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.183
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.172
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.153
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.097
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.096
Cannabinoid-opioid interaction in relapse to drug-seeking 1.089
Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone 1.077
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.064
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.058
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs 1.033
Endocannabinoid system and opioid addiction: behavioural aspects 1.030
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 979
Analysis of opioid-seeking behavior through the intravenous self-administration reinstatement model in rats 979
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives 972
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 964
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 958
Reduction of Corticostriatal Glutamatergic Fibers in Basic Fibroblast Growth Factor Deficient Mice is Associated with Hyperactivity and Enhanced Dopaminergic Transmission 886
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 878
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 851
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. 820
Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil 820
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 799
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 792
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 791
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 772
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 753
null 738
SYNTHETIC AND PLANT-DERIVED CANNABINOID RECEPTOR ANTAGONISTS SHOW HYPOPHAGIC PROPERTIES IN FASTED AND NON-FASTED MICE 738
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 714
null 711
Totale 199.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 315.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 315.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.875 0 0 0 0 1.262 804 613 627 1.023 1.282 1.239 1.025
2022/202317.564 1.499 2.292 2.442 1.486 1.397 1.700 815 1.319 1.127 1.154 1.575 758
2023/202417.789 903 649 829 1.222 1.746 3.337 2.416 1.109 990 1.311 1.598 1.679
2024/202539.679 8.541 8.982 5.311 4.107 1.965 2.205 3.168 299 514 3.551 438 598
2025/202614.204 1.172 700 1.353 1.220 975 975 2.012 511 2.710 1.421 818 337
2026/20275.415 774 1.605 1.106 1.706 224 0 0 0 0 0 0 0
Totale 235.967